Ending the Evidentiary & Insurance Reimbursement Bias Against Neurofeedback to Treat Attention Deficit/Hyperactivity Disorder: It Will Take Clinician Action in Addition to the Compelling Science
Description:
This article argues against the treatment of Attention deficit/hyperactivity disorder (ADHD) with stimulant medication and behavior therapy, which are also typically reimbursed by healthcare insurers. Evidence suggests that these treatments fail to result in sustained benefit for the vast majority of children who receive them as demonstrated in the NIMH-funded MTA Cooperative study, the gold standard study in ADHD treatment effectiveness research. The authors instead look at the use of neurofe…
more
Date:
August 23, 2016
Creator:
Pigott, H. Edmond; Bodenhamer-Davis, Eugenia; Davis, Richard E. & Harbin, Henry
Item Type:
Refine your search to only
Article
Partner:
University of North Texas